相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarkers for Hepatobiliary Cancers
Jean-Charles Nault et al.
HEPATOLOGY (2021)
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
Tan Boon Toh et al.
JOURNAL OF HEPATOLOGY (2020)
Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
Yasuyuki Tamai et al.
PLOS ONE (2020)
The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma
Wenjing Gong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma
Yi-Ju Wu et al.
CELL DEATH & DISEASE (2019)
A prognostic prediction system for hepatocellular carcinoma based on gene co-expression network
Lianyue Guan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma
Sufang Wang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
Qi Zhang et al.
GUT (2019)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma
Zhikun Liu et al.
MOLECULAR CARCINOGENESIS (2018)
GeneMANIA update 2018
Max Franz et al.
NUCLEIC ACIDS RESEARCH (2018)
An insight into the complex roles of metallothioneins in malignant diseases with emphasis on (sub)isoforms/isoforms and epigenetics phenomena
Sona Krizkova et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma
Biwei Yang et al.
NATURE COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The roles of metallothioneins in carcinogenesis
Manfei Si et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma
Ju-deng Zeng et al.
JOURNAL OF CANCER (2018)
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
Otilia Menyhart et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Le-Xing Yu et al.
NPJ PRECISION ONCOLOGY (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions
Cheol-Hee Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Gene expression patterns in the progression of canine copper-associated chronic hepatitis
Karen Dirksen et al.
PLOS ONE (2017)
Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway
Yulong Zheng et al.
BMC CANCER (2017)
Epigenetics in liver disease: from biology to therapeutics
Timothy Hardy et al.
GUT (2016)
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
Aline Houessinon et al.
MOLECULAR CANCER (2016)
Autophagy of metallothioneins prevents TNF-induced oxidative stress and toxicity in hepatoma cells
Chiara Ullio et al.
AUTOPHAGY (2015)
Update on Biomarkers of Hepatocellular Carcinoma
Roongruedee Chaiteerakij et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium
Laura Cartularo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma
Silvia Udali et al.
CLINICAL EPIGENETICS (2015)
MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
Xiang-Fen Ji et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Metallothionein IF and 2A overexpression predicts poor outcome of non-small cell lung cancer patients
Bozena Werynska et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma
Yangsoon Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Metallothionein 1h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1
Yu-Chen Han et al.
JOURNAL OF PATHOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas
Keith M. Skubitz et al.
CANCER (2012)
Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas
Jun Mao et al.
CARCINOGENESIS (2012)
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
Edoardo G. Giannini et al.
HEPATOLOGY (2012)
Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?
Charing Ching-Ning Chong et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2012)
Whole genome analysis and microRNAs regulation in HepG2 cells exposed to cadmium
Marco Fabbri et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2012)
CpG Island Methylation Profiling in Human Salivary Gland Adenoid Cystic Carcinoma
Achim Bell et al.
CANCER (2011)
Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy
Yi Shuai et al.
TOXICOLOGY LETTERS (2011)
Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone
L. Endo-Munoz et al.
BRITISH JOURNAL OF CANCER (2010)
Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways
Y. K. J. Leung et al.
EXPERIMENTAL NEUROLOGY (2010)
Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma
Valeria R. Mas et al.
MOLECULAR MEDICINE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Molecular mechanisms of alcohol-mediated carcinogenesis
Helmut K. Seitz et al.
NATURE REVIEWS CANCER (2007)
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach et al.
HEPATOLOGY (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Comparative transcriptome maps:: a new approach to the diagnosis of colorectal carcinoma patients using cDNA microarrays
E Jansová et al.
CLINICAL GENETICS (2006)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Gene expression patterns in human liver cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Metallothionein: The multipurpose protein
P Coyle et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
分享论文
